Elise Langenkamp
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Epigenetics and DNA Methylation, Histone Deacetylase Inhibitors Research, Cancer Genomics and Diagnostics, Angiogenesis and VEGF in Cancer
Most-Cited Works
- → VEGF suppresses T‐lymphocyte infiltration in the tumor microenvironment through inhibition of NF‐κB‐induced endothelial activation(2014)181 cited
- → Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF‐A and TGFβ2 in vascular abnormalization(2012)167 cited
- → Identification of Epigenetically Silenced Genes in Tumor Endothelial Cells(2007)138 cited
- → Microvascular endothelial cell heterogeneity: general concepts and pharmacological consequences for anti-angiogenic therapy of cancer(2008)118 cited
- → Elevated Expression of the C-Type Lectin CD93 in the Glioblastoma Vasculature Regulates Cytoskeletal Rearrangements That Enhance Vessel Function and Reduce Host Survival(2015)96 cited
- → EMPIRICAL VALIDATION OF A RAT IN VITRO ORGAN SLICE MODEL AS A TOOL FOR IN VIVO CLEARANCE PREDICTION(2006)46 cited
- → Innovations in studying in vivo cell behavior and pharmacology in complex tissues – microvascular endothelial cells in the spotlight(2013)20 cited
- → Tumor Vascular Morphology Undergoes Dramatic Changes during Outgrowth of B16 Melanoma While Proangiogenic Gene Expression Remains Unchanged(2011)11 cited
- → Vascular endothelial growth factor receptor 2 inhibition in-vivo affects tumor vasculature in a tumor type-dependent way and downregulates vascular endothelial growth factor receptor 2 protein without a prominent role for miR-296(2011)11 cited
- → Supplementary Table 3 from Identification of Epigenetically Silenced Genes in Tumor Endothelial Cells(2023)